Therapeutic drug option for dyslipaemia

被引：1
作者：
Maiques Galan, Antonio [1 ]
Brotons Cuixart, Carlos [2 ]
机构：
[1] Ctr Salud Manises, Valencia, Spain
[2] Serv Catala Salud, CAP Sardenya, Barcelona, Spain
来源：
ATENCION PRIMARIA | 2010年 / 42卷 / 02期
关键词：
CARDIOVASCULAR-DISEASE PREVENTION; DENSITY-LIPOPROTEIN CHOLESTEROL; STATIN THERAPY; EFFICACY; SAFETY; METAANALYSIS; SIMVASTATIN; EZETIMIBE; ATORVASTATIN; COMBINATION;
D O I：
10.1016/j.aprim.2009.04.008
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
[No abstract available]
引用
收藏
页码：115 / 120
页数：6
相关论文
共 31 条
  • [1] The safety of niacin in the US Food and Drug Administration Adverse Event Reporting database
    Alsheikh-Ali, Alawi A.
    Karas, Richard H.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (8A) : 9B - 13B
  • [2] Amarenco P, 2006, NEW ENGL J MED, V355, P549
  • [3] Standards of medical care in diabetes 2008
    不详
    [J]. DIABETES CARE, 2008, 31 : S12 - S54
  • [4] [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360
  • [5] Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia
    Athyros, VG
    Papageorgiou, AA
    Athyrou, VV
    Demitriadis, DS
    Kontopoulos, AG
    [J]. DIABETES CARE, 2002, 25 (07) : 1198 - 1202
  • [6] Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
    Baigent, C
    Keech, A
    Kearney, PM
    Blackwell, L
    Buck, G
    Pollicino, C
    Kirby, A
    Sourjina, T
    Peto, R
    Collins, R
    Simes, J
    [J]. LANCET, 2005, 366 (9493) : 1267 - 1278
  • [7] Effects of torcetrapib in patients at high risk for coronary events
    Barter, Philip J.
    Caulfield, Mark
    Eriksson, Mats
    Grundy, Scott M.
    Kastelein, John J. P.
    Komajda, Michel
    Lopez-Sendon, Jose
    Mosca, Lori
    Tardif, Jean-Claude
    Waters, David D.
    Shear, Charles L.
    Revkin, James H.
    Buhr, Kevin A.
    Fisher, Marian R.
    Tall, Alan R.
    Brewer, Bryan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21) : 2109 - 2122
  • [8] Bays Harold E, 2007, Am J Ther, V14, P567, DOI 10.1097/MJT.0b013e31815a69fc
  • [9] Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds - A meta-analysis of randomized controlled trials
    Birjmohun, RS
    Hutten, BA
    Kastelein, JJP
    Stroes, ESG
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (02) : 185 - 197
  • [10] Simultaneous low-density lipoprotein-C lowering and high-density lipoprotein-C elevation for optimum cardiovascular disease prevention with various drug classes, and their combinations: a meta-analysis of 23 randomized lipid trials
    Brown, B. Greg
    Stukovsky, Karen Hinckley
    Zhao, Xue-Qiao
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2006, 17 (06) : 631 - 636
1234